Presentation is loading. Please wait.

Presentation is loading. Please wait.

Medium chain acyl CoA dehydrogenase deficiencyMCADD June 28, 2011 APHL-CDC Carlos A. Saavedra-Matiz, MD Newborn Screening Program Wadsworth Center New.

Similar presentations


Presentation on theme: "Medium chain acyl CoA dehydrogenase deficiencyMCADD June 28, 2011 APHL-CDC Carlos A. Saavedra-Matiz, MD Newborn Screening Program Wadsworth Center New."— Presentation transcript:

1 Medium chain acyl CoA dehydrogenase deficiencyMCADD June 28, 2011 APHL-CDC Carlos A. Saavedra-Matiz, MD Newborn Screening Program Wadsworth Center New York State Department of Health

2 Humpath.com

3 http://web.virginia.edu/Heidi/chapter24/chp24.htm

4 http://www.ncbi.nlm.nih.gov/books/NBK28177/figure/A2964 http://www.newbornscreening.info/Parents/fattyaciddisorders/MCADD.html

5 Fatty Acid Oxidation Disorders Genetically determined inborn errors of metabolism Myopathy/cardiomyopathy/SIDS Initial presentacion: Hypoketotic hypoglycemia Abnormal response to fasting and/or infectious disease stress Fasting >12 exhaust glycogen and mobilizes FAO Overlapping specificities for chain length dehydrogenases

6 Medium chain acyl CoA dehydrogenase deficiency 1/6,000-10,000 caucasian births Most common/Classic FAO disorder Present as hypoketotic/hypoglycemic (Reye Sx) and/or myo/cardiomyophaty, hypotonia, CHF, arrhythmia, SIDS Episodic illness 6m–2y after 12 h fasting or intercurrent infectious disease (vomiting / lethargy / seizures / coma) Most patients normal between episodes / some hypotonic or poor muscle strength

7 Acyl CoA Dehydrogenases / Substrate specificities EnzymeSubstrate Chain length Deficiency Disease Short Chain (SCAD)C4-6Rare Medium-chain (MCAD)C6-12Common (1:10,000) Very long-chain (VLCAD)C12-16Rare MCAD is one of three mitochondrial Acyl CoA dehydrogenases The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway MCAD substrates are fatty acyl CoAs with acid chain length of C6-C12 The examination of DBS by MS/MS to establish an Acylcarnitine Profile is the method used by the NYS-NBSP Elevation of octanoylcarnitine (C8) is the main marker C6 and ratio C8:C2 help as discriminators

8 C8 C8-IS C6 Courtesy Dr. M. Morrissey NBSP-NYSDOH NYSDOH-NBSP MCADD MS/MS Detection

9 p.Y67H 1010 9 8 7 6 5 4 3 2 1 1 1212 5’ UTR region 3’ UTR region p.K329E c.-1028 T>C c.-1375 G>C c.-985 C>G c.-725 C>G c.-257 G>Ap.M1R p.G310R p.T121I p.R206H p.W82Lfsx23 p.R243Q p.G402D p.Y145H p.T193A p.R29X Autosomal recessive Gene (ACADM) on chromosome 1p31.1 12 exons, 421 amino acids c.985A>G (p.Lys329Glu = p.K304E) most common mutation C8>0.8 μmole/L are referred for DNA analysis NYS-NBSP uses FRET/RT-PCR to detect p.K329E Complete gene sequencing Genetics

10 Wtc.985A>G MCADD c.985A>G = p.K329E (K304E) NYSDOH-NBSP FRET analysis most common ACADM Mutation

11 c.DNAProteinHomoHetCarrier FreqAllele Freq c.985A>Gp.K329E201973.655.7 c.199T>Cp.Y67H0713.26.6 c.843A>Tp.R281S023.81.9 c.449_452del4p.T150RfsX4023.81.9 c.1257C>Ap.Y394X101.9 c.443G>Ap.R148K101.9 c.331G>Ap.E111K101.9 C.320T>Cp.L107S101.9 c.617G>Ap.R206H011.90.9 c.567delGp.M190CfsX3011.90.9 c.526G>Ap.A176T011.90.9 c.166G>Ap.A56P011.90.9 Modified from: Arnold GL, Saavedra-Matiz CA et al. Mol Genet & Met 99(2010)263-8


Download ppt "Medium chain acyl CoA dehydrogenase deficiencyMCADD June 28, 2011 APHL-CDC Carlos A. Saavedra-Matiz, MD Newborn Screening Program Wadsworth Center New."

Similar presentations


Ads by Google